SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial

Clinical trial NCT06674109 · RECRUITING

Trial details

NCT number: NCT06674109
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Gout and Hyperuricemia

Start date: 2026-07-01
Primary completion: 2028-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.